2nd Quarter - Amendment
WINNING STRATEGIES WASHINGTON for NOVARTIS
Client
Income
$40,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2012 | $40,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Oct 4, 2012 | $40,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY13 Department of Defense Appropriations Orphan drugs and tax issues PDUFA
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Health Issues HCR
Patient Protection and Innovative Biologic Medicines Act of 2009 Implementation of health care reform Implementation and progress of the deficit reduction committee
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.